If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password
). Whether there is decreased neural activity in olfactory pathways despite normal morphology is unknown. We sought to assess the neural metabolic activity in anosmia of COVID-19 by 18fluoro-2-deoxy-d-glucose (18FDG) positron emission tomography–computed tomography (PET-CT).
We included a 27-year-old healthy, right-handed woman, diagnosed with COVID-19 by polymerase chain reaction assay. The patient had persistent isolated anosmia for 6 weeks. She had no history of alcohol intake or tobacco smoking and no background of psychiatric problems. The patient was asked to fast for 6 hours prior to imaging. We performed 18FDG-PET/CT in a neutral environment using 5 ml of aerosolized 0.9% NaCl delivered with O2 at 3.5 ml/min via facial mask for 9 minutes. The patient was instructed to breath normally without sniffing. After 3 minutes, the patient received intravenous 18FDG (4.6 Megabecquerel/kg, Masih Daneshvari Hospital, Tehran), and the neutral olfactory condition continued for another 6 minutes. The patient laid down in a semi-darkened, noiseless, and odorless room, with her eyes closed. After an uptake time of 60 minutes, the brain and whole-body PET/CT scan was performed with sequential TOF-PET/CT (Discovery 690 PET/CT with 64 slices, GE Healthcare, USA). The PET tomography consisted of LYSO (Lu1.8Y0.2 SiO5 (Ce)) crystals with dimensions of 4.2 × 6.3 × 25 mm3. Data was acquired in 3D mode with scan duration of 10 minutes for the brain scan and 2 minutes per bed position for the whole-body scan. The images were reviewed by a nuclear medicine physician and a radiologist with substantial experience in PET/CT reporting in consensus.
The PET-CT images suggested hypometabolism of the left orbitofrontal cortex (Fig 1). The standardized uptake value (SUV) of 9.5 on the left side was reduced compared with the SUV of 10 on the right side. Our finding is in contrast to higher metabolic activity of the left orbitofrontal cortex compared with the right side in right-handed subjects with normal olfaction (
). The FDG uptake in the left inferior temporal cortex was normal (Fig 1).
Olfactory perception is a sophisticated chemosensory process involving different parts of the cerebral cortices, mainly orbitofrontal and limbic system. Peripherally located olfactory dendrites within receptor cells that connect to the central nervous system (ie, olfactory bulb) may provide a route for neuro-invasion in SARS-CoV-2-induced anosmia (
There are two separate subsystems for smelling and sniffing resulting in stimulation of different cerebral cortices, and therefore, asymmetric cortical activity. Under olfactory condition (using a pure odor), Cuneus, lingual gyrus, and parahipocampal gyrus have higher glucose metabolic activity mainly in the left hemisphere in right-handed subjects (
). In contrast, under neutral condition (normal saline used in our study), superior, middle, inferior, medial frontal, and orbital gyrus (ie, orbitofrontal cortex) as well as anterior cingulate gyrus have higher metabolic activity on the left-side compared to the right-side in right-handed subjects.
Orbitofrontal cortex is responsible for detection of common odors and on FDG-PET-CT has a lower uptake under olfactory condition than under neutral condition (
). The present study examined the FDG uptake patterns under neutral condition. To elucidate the full spectrum of olfactory abnormalities in anosmia of COVID-19, it is necessary to perform 18FDG-PET-CT under olfactory condition in future studies.
In conclusion, to the best of our knowledge, this is the first report of reduced metabolic activity in the orbitofrontal cortex in anosmia of COVID-19, suggesting impaired neural function in this region as an underlying cause of anosmia, likely due to direct neurotropism of SARS-CoV-2.
De Riu G.
Anosmia and ageusia: common findings in COVID-19 patients.